Abstract Mitochondrial DNA deletions (D-mtDNA) have been implicated in the pathogenesis of Alzheimer's disease (AD), multiple sclerosis (MS) and Parkinson's disease (PD), as well as ageing. Clonal expansion of D-mtDNA is the process by which a mutant mtDNA molecule increases to high levels within a single cell containing both wild-type and mutant mtDNA. Unlike in AD and PD, the diffuse inflammatory process in MS involves the choroid plexus, and mitochondria are exposed to reactive oxygen and nitrogen species over a prolonged period. We determined the extent of respiratory enzyme deficiency and D-mtDNA at a single cell level within choroid plexus epithelial cells in MS as well as in AD, PD and controls. The respiratory enzyme-deficient (lacking complex IV and with intact complex II activity) cells were more prevalent within the choroid plexus in AD, MS and PD compared with controls. The main catalytic subunit of complex IV (subunit-I of cytochrome c oxidase) was lacking in significantly more respiratory enzyme-deficient cells in MS compared with AD, PD and controls. The single cell analysis showed a fourfold increase in the percentage of respiratory enzymedeficient choroid plexus epithelial cells harbouring clonally expanded D-mtDNA in MS. Our findings establish clonal expansion of D-mtDNA as a feature relatively more prominent within the choroid plexus epithelium in MS than AD, PD or controls. We propose clonal expansion of D-mtDNA as a molecular link between inflammation and part of a delayed cellular energy failure in MS.
Introduction

Mitochondrial defects have been implicated in the pathogenesis of multiple sclerosis (MS) as well as Parkinson's
Electronic supplementary material The online version of this article (doi:10.1007/s00401-012-1001-9) contains supplementary material, which is available to authorized users. disease (PD), Alzheimer's disease (AD) and ageing [2, 4, 12, 22, 23, 25, 32, 37, 44] . Unlike PD and AD, there is chronic and diffuse inflammation with associated reactive oxygen and nitrogen species (RONS) and multifocal demyelination in MS [16, 18, 20] . Mitochondrial DNA (mtDNA), the only non-nuclear DNA, is particularly susceptible to RONS-mediated damage [5] . In MS, the extent of diffuse inflammation and prolonged disease duration may lead to an excess of mtDNA-led mitochondrial respiratory chain defects within CNS cells compared to controls.
MtDNA encodes functionally important subunits of the mitochondrial respiratory chain complexes [with the exception of succinate dehydrogenase (SDH) or complex II] [25] . Following double strand breaks in mtDNA, repair mechanisms are thought to generate deletions of mtDNA (D-mtDNA) [17, 24] . The proportion of D-mtDNA as a percentage of total mtDNA copies (heteroplasmy) in single cells needs to exceed a threshold ([50 %) for a biochemical defect to manifest from D-mtDNA [24, 25] . In chronically inflamed MS tissue, D-mtDNA led respiratory enzyme deficiency [lack of cytochrome c oxidase (complex IV) with intact SDH activity] may be due to ongoing mutagenesis of mtDNA by RONS leading to the accumulation of multiple species of D-mtDNA. Despite the likelihood of ongoing mutagenesis of mtDNA in MS, our previous single cell findings within neurons in MS suggested clonal expansion of D-mtDNA (increase in the level of D-mtDNA in single cells due to expansion of one clone of mutant mtDNA) [6] . However, single cell studies to confirm clonal expansion of D-mtDNA within neurons in MS were not possible due to technical limitations (the small size of respiratory enzyme-deficient neurons in MS). Furthermore, demyelination, which is now recognized to influence mitochondrial content, function and dynamics within axons, may also influence mitochondria within the neuronal soma [21, 26, 45, 47] .
The choroid plexus (CP) epithelium, whilst being detached from demyelination, is metabolically highly active and forms the blood-cerebrospinal fluid (CSF) barrier [7, 35] . Besides producing CSF, the CP is involved in the secretion, absorption and transport of a number of proteins, metabolites and neurotransmitters [40, 46] . Given the chronicity of inflammation and the involvement of the CP in MS [14, 43] , we hypothesized that the CP epithelium in MS harbours respiratory enzyme-deficient cells as a result of D-mtDNA, either as a result of clonal expansion or ongoing mutagenesis. The key requirements for clonal expansion of D-mtDNA include mtDNA replication and sufficient time; clonal expansion of D-mtDNA is hypothesized to be a gradual and random process that occurs at a single cell level in a number of neurodegenerative disorders (thought to require years or decades) and with ageing [17, 25, 28] . Respiratory enzyme-deficient CP epithelial cells were reported in AD and aged controls [9, 10] , although mtDNA has not been previously investigated in the CP [3, 8] . We found that CP epithelium in MS harboured significantly more respiratory enzyme-deficient cells than controls and AD, despite the age difference (MS cases being younger). A significantly greater proportion of respiratory enzymedeficient cells harboured a high level of D-mtDNA ([50 %) in MS compared with PD, AD and controls. Using longrange PCR and single-molecule PCR, more than one clone of D-mtDNA was rarely detected within single respiratory enzyme-deficient cells, despite ongoing inflammation and evidence supporting elevated RONS in MS. These results establish clonal expansion of D-mtDNA as a mechanism of respiratory enzyme deficiency in a structure that is not directly affected by demyelination in MS.
Materials and methods
Autopsy material
Snap frozen blocks of CP from MS (n = 10), PD (n = 5), AD (n = 5) and control (n = 9) cases were obtained from the UK PD and MS Tissue Bank at Imperial College, NeuroResource (UK), Cleveland Clinic Foundation and Newcastle Brain Tissue Resource (Supplementary Table 1 ). All tissues were collected following fully informed consent. Neuropathological confirmation and characterization of the cases and the exclusion of CNS pathology in controls were performed by the individual tissue banks according to the internationally accepted criteria. Newcastle and North Tyneside Local Research Ethics Committee approved the study (05/Q0906/182).
Complex IV/complex II histochemistry
Cryostat sections (10 lm thickness) were placed on glass and membrane slides. To assess complex IV and complex II activity, a histochemical assay was applied sequentially as previously described [31, 36] . Nuclei were identified using Hoechst stain (50 %) followed by 100 % ethanol for 10 min and Histoclear prior to mounting.
Immunofluorescent histochemistry
To ascertain the status of subunit-I of complex IV and inflammatory markers on respiratory enzyme-deficient cells, immunofluorescence histochemistry was carried out on cryostat sections on glass slides following complex IV histochemistry, as previously described [27] . Respiratory enzyme-deficient cells were identified by intense complex II 70 kDa or porin labelling. Sections on membrane slides were used for real-time PCR of respiratory enzyme-deficient cells with and without complex IV subunit-I.
Immunohistochemistry
Inflammatory cells and sources of RONS were identified using the Menapath X-Cell Plus HRP Polymer Detection System [27] . Cryostat sections were fixed in 4 % paraformaldehyde for 30 min and either immersed in EDTA pH = 8.0 (boiling) or methanol gradient (70-100 %) with reversal. Primary antibodies were applied and detected with Menapath system and DAB (Supplementary Table 2) . Vector Ò VIP chromogen was used when immunohistochemistry was preceded by complex IV histochemistry.
Laser microdissection and real-time PCR analysis
Respiratory enzyme-deficient CP epithelial cells and those with intact complex IV activity were randomly selected and laser captured from cryostat sections placed on membrane slides (10 lm thickness, in order to minimize contamination from tissue placed above and below the plan of the selected cell) following complex IV/complex II histochemistry and complex IV histochemistry/immunofluorescence histochemistry for complex IV subunit-I. DNA was extracted and heteroplasmy levels were determined using real-time PCR (MTND1/MTND4), as previously described [2, 6, 22, 23] . All samples including deletion standards, no template and blood controls were run in triplicate.
Long-range PCR
A two-step long-range PCR was carried out on the major arc of the mitochondrial genome using the Expand Long Template PCR System to detect D-mtDNA, as previously described [6, 11] . DNA was extracted from 20 pooled cells and then single cells (respiratory enzyme-deficient and cells with intact complex IV activity). Control blood DNA was used as wild type. DNA products were separated using a 0.7 % agarose gel containing ethidium bromide and viewed under UV light.
Gel extraction and sequencing
To confirm D-mtDNA and assess breakpoints, DNA was extracted from agarose gels using the Qiagen gel extraction kit. Cycle conditions for sequencing were as previously reported [6, 11] . Sequences, obtain using ABI 3100 Genetic Analyser, were compared with the revised Cambridge Reference Sequence.
Single-molecule PCR
Clonally expanded D-mtDNA in single respiratory enzyme-deficient CP epithelial cells was confirmed using single-molecule PCR, as previously described [22] . DNA samples were diluted in TE buffer and diluted DNA was added to a mastermix with components according to the manufacturer's guidelines (TaKaRa Mirrus Bio Madison WI). 31 cycles of first-stage PCR consisted of 20 s at 95°C and 16 min at 68°C. A second-stage reaction mix was added at this point followed by a further 15 cycles at the above conditions. Primers used in the first stage were 3160F32 and 3710R36 or 10161F31 and 10937R31, whilst 3204F34 and 3710R36 or 10195F30 and 10853R35 were used in the second stage. PCR products were viewed on a 2 % agarose gel containing ethidium bromide and viewed under UV light.
Terminal deoxynucleotidyl transferase-mediated dUDP nick-end labelling Following complex IV histochemistry, terminal deoxynucleotidyl transferase-mediated dUDP nick-end labelling (TUNEL) was performed, as per manufacturer's guidelines (Roche).
Microscopy and quantitation of immunoreactivity and respiratory enzyme-deficient cells
Respiratory enzyme-deficient (blue cells) and cells with intact complex IV activity (brown) in CP epithelium were quantified using complex IV/complex II histochemistry images captured at 920 magnification and AxioVision 4.8. A mean of 1,327 ± 146 cells, with a nucleus stained by Hoechst, were included per case. To determine complex IV subunit-I status within respiratory enzymedeficient cells in MS and controls, combined bright field and fluorescent images of sequential complex IV histochemistry and immunofluorescent histochemistry were taken on a Zeiss Axioimager 2. Complex IV subunit-I status (FITC) in 20 respiratory enzyme-deficient cells, per case, labelled with complex II 70 kDa (rhodamine) was determined as either positive or negative. For sources of RONS, Vector Ò VIP positive cells in stroma were identified in images of sections with sequential complex IV histochemistry and immunohistochemistry, taking care to exclude cells within blood vessels. Using the same sections, respiratory enzyme-deficient CP epithelial cells with and without evidence of RONS were analysed. Inflammatory cells with discrete labelling (CD68 and CD3) were imaged and quantitated as cell density. HLA and CD163 immunoreactivity was densitometrically analysed using Image J, keeping threshold constant between cases, as individual cells were difficult to discriminate. Cell densities and densitometric values were determined per area of CP.
Statistics
GraphPad prism 4 was used for all statistics. Non-parametric tests (Kruskal-Wallis test and Mann-Whitney U test) were used to compare parameters between groups, as data were unevenly distributed. A P value of \0.05 was considered to be significant.
Results
Respiratory enzyme-deficient cells were more abundant within choroid plexus epithelium in MS, PD and AD than in controls
We detected respiratory enzyme-deficient CP epithelial cells (blue, Fig. 1a-d) in MS, PD, AD and controls. Respiratory enzyme-deficient cells were larger than cells with intact complex IV activity (brown, Fig. 1e ; Supplementary Table 3 ), consistent with the 'oncocytic' appearance [9, 10, 41] . In MS, PD and AD, a significantly greater percentage of CP epithelial cells were respiratory enzyme deficient than controls (Fig. 1f, g ). In all four groups, the density of respiratory enzyme-deficient CP epithelial cells increased with age. In MS, the disease duration correlated significantly with the extent of respiratory enzyme deficiency (r 2 = 0.49 and P = 0.025, Supplementary Fig. 1 ). However, the respiratory deficiency in cases with \15 years of disease duration did not significantly differ from those with [15 years. Although the mean age of MS cases and controls were similar, PD and AD cases were significantly older than controls (Supplementary Table 1 ). None of the respiratory enzymedeficient cells in the four groups were positive for markers of inflammation (HLA and CD68, Supplementary Fig. 2 ) or apoptosis (TUNEL and AIF, not shown).
A greater proportion of respiratory enzyme-deficient cells were devoid of subunit-I of cytochrome c oxidase in MS than PD, AD and controls
The status of mtDNA encoded subunit-I of complex IV, essential for its activity, was investigated in respiratory enzyme-deficient CP epithelial cells (Fig. 2a-f ). Intense nuclear encoded complex II 70 kDa labelling, following complex IV histochemistry, identified the respiratory enzyme-deficient epithelial cells (Fig. 2bi) . The percentage of respiratory enzyme-deficient cells lacking complex IV subunit-I was significantly greater in MS than in AD, PD and controls (Fig. 2g) . The above observations raised the possibility of D-mtDNA led respiratory enzyme deficiency in CP epithelial cells.
High levels of mitochondrial DNA deletions were apparent in a greater percentage of respiratory enzymedeficient cells within choroid plexus epithelium in MS than PD, AD and controls To establish whether D-mtDNA caused respiratory enzyme deficiency, we laser captured single CP epithelial cells (Fig. 3a) from MS, PD, AD and controls and used an established real-time PCR assay to determine the level of D-mtDNA at a single cell level [2] . In randomly selected respiratory enzyme-deficient cells, the mean level of D-mtDNA was significantly greater in MS cases (25.23 %, P \ 0.001) than in PD (8.59 %), AD (9.24 %) and control (11.87 %) cases (Fig. 3b-f ). The proportion of respiratory enzyme-deficient cells, in which the level of D-mtDNA was sufficient to cause a biochemical defect ([50 %) was significantly greater in MS (29.27 %) than PD (3.78 %), AD (6.21 %) and controls (7.75 %). The high level of D-mtDNA ([ 50 %) was not detected in any of the CP epithelial cells with intact complex IV activity (Supplementary Fig. 3a-d) . Furthermore, none of the respiratory enzyme-deficient CP epithelial cells with complex IV subunit-I in MS contained high level of D-mtDNA [mean heteroplasmy level of 17.64 ± 4.43 % (n = 14) compared with 42.91 ± 8.38 % (n = 10) in respiratory enzymedeficient cells without complex IV subunit-I (P = 0.008)]. Table 1 ). The difference in the density of respiratory enzyme-deficient cells between MS and PD CP was not statistically significant. A mean of 1,327 ± 146 cells, with a nucleus stained by Hoechst, were included per case. g The proportion of respiratory enzyme-deficient cells in the choroid plexus and age significantly correlated in MS (P = 0.037 and r 2 = 0.439), AD (P = 0.049 and r 2 = 0.775) and controls (P = 0.037 and r 2 = 0.485). There was a trend towards an increase in the density of respiratory enzyme-deficient cells with age, which was not statistically significant, in PD, where the age range was narrow (Table 1) Clonally expanded mitochondrial DNA deletions within respiratory enzyme-deficient choroid plexus epithelial cells in MS As the next step, we characterized the D-mtDNA within respiratory enzyme-deficient cells in MS to determine whether high levels of D-mtDNA were due to ongoing mutagenesis and accumulation of multiple D-mtDNA within single cells or clonal expansion of D-mtDNA. When DNA extracted from 20 pooled respiratory enzyme-deficient cells (per lane in Fig. 4a ) was used for long-range PCR, we detected multiple D-mtDNA which were more prominent in MS than PD, AD or controls. Because of the relatively large dimensions of CP epithelial cells (compared with neurons and glia, Supplementary Table 3) , we were able to study D-mtDNA within single cells in detail (Fig. 4b-e) , including characterization at a single-molecule level. When DNA extracted from single respiratory enzyme-deficient cells was used for long-range PCR (one cell per lane in Fig. 4b ), different sized D-mtDNA were detected in different cells and more than one clone of D-mtDNA was rarely detected within a single cell. Sequencing of large-scale D-mtDNA extracted from gels following long-range PCR confirmed the presence of D-mtDNA and identified the breakpoints (Fig. 4c, d ; Table 1 ). As previously reported in PD and primary mitochondrial disorders, some of the breakpoints of D-mtDNA in MS tissue were flanked by either perfect or imperfect repeat sequences [24] , which have been implicated in models of D-mtDNA formation ( Table 1) . As a single clone of D-mtDNA in respiratory enzyme-deficient cells judged by long-range PCR was suggestive of clonal expansion, we extracted DNA from single respiratory enzyme-deficient CP epithelial cells, diluted to a single copy of mtDNA per reaction and performed single-molecule PCR on multiple occasions (at least three times per cell). In separate reactions of single mtDNA molecules from single respiratory enzyme-deficient cells, only one clone of D-mtDNA (a hallmark of clonal expansion of D-mtDNA) or full-length product was detected (Fig. 4e) . Fig. 2 The status of subunit-I of cytochrome c oxidase or complex IV (complex IV subunit-I) within respiratory enzyme-deficient cells in multiple sclerosis and controls. a-f Subunits of complex II (SDH) and complex IV in respiratory enzyme-deficient choroid plexus (CP) epithelial cells were identified by immunofluorescently labelled complex II 70 kDa (red) and complex IV subunit-I (green) following complex IV histochemistry. As previously reported [27] , respiratory chain complex subunits were barely detectable in cells with intact complex IV activity, due to deposits of complex IV reaction product (a and d in brown and c and f in grey scale) interfering with antibody binding. Complex II 70 kDa (red), and porin (not shown), was detected in all respiratory enzyme-deficient cells (bi and ei, arrows and arrowheads), which supports histochemically detected SDH activity in respiratory enzyme-deficient cells (Fig. 1a-e) . In contrast to complex II 70 kDa, complex IV subunit-I was detected in a subset of respiratory enzyme-deficient cells in MS (bii and eii, arrows) and controls. The overlap images of bright field and immunofluorescent figures identified the respiratory enzyme-deficient cells and confirmed the presence or absence of complex IV subunit-I (arrows and arrowheads, respectively) within the respiratory enzyme-deficient CP epithelial cells (a-f). g The percentage of respiratory enzymedeficient CP cells lacking complex IV subunit-I was significantly greater in MS (64.6 ± 4.7 %, *P \ 0.001) than AD (44.7 ± 5.1 %), PD (36.4 ± 3.9 %) and controls (43.3 ± 4.8 %). 20 respiratory enzyme-deficient epithelial cells per case were randomly selected to determine the status of complex IV subunit-I in MS cases (n = 10) and controls (n = 9). Complex IV cytochrome c oxidase, SDH succinate dehydrogenase Fig. 3 Heteroplasmy level of D-mtDNA within laser captured respiratory enzyme-deficient choroid plexus epithelial cells. a Complex IV/complex II histochemistry was performed on sections placed on membrane slides for laser capture microdissection (a). Respiratory enzyme-deficient choroid plexus (CP) epithelial cells (ai, blue) were randomly selected and captured following laser microdissection (aii) into the cap of Eppendorf tubes (aiii, arrow and inset indicate a single cell following laser capture). CP epithelial cells with intact complex IV activity (brown) were also laser captured (see Supplementary  Fig. 3 ). Scale bar 1,000 lm. .3 ± 4.2 %, P \ 0.001) compared with PD (3.8 ± 1.1 %), AD (6.2 ± 0.8 %) and controls (7.8 ± 0.5 %). Kruskal-Wallis test P \ 0.001. The D-mtDNA led respiratory enzyme deficiency in MS was despite the cases been younger, on average, than PD and AD cases (Table 1) . Complex IV cytochrome c oxidase, SDH succinate dehydrogenase Reactive oxygen and nitrogen species within the choroid plexus in MS, PD, AD and controls Although inflammation in MS involves the CP, sources of RONS have not been reported within CP in MS [15, 43] . We detected and quantitated sources of superoxide [nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and myeloperoxidase (MPO)] and nitric oxide (NO) within the CP using antibodies against NADPH oxidase subunits (NOX1 and p22phox), MPO and inducible NO synthase (c, d) . In a proportion of D-mtDNA, the sequence that flanked the breakpoints showed perfect or imperfect repeats (see Table 2 ). The repeat sequence of an imperfect repeat is underlined on the 3 0 end from the breakpoint, with the imperfect base shown above the sequence in bold (c). D-mtDNA without repeat sequences were also detected within respiratory enzyme-deficient cells in MS (d). e Clonality of D-mtDNA in respiratory enzyme-deficient CP cells was confirmed using single-molecule PCR. Long-range PCR was performed multiple times from the diluted DNA of six individual cells. Three representative positive reactions are presented for each of six respiratory enzyme-deficient cells from MS. Note that each cell contained only one species of mtDNA molecule: either full-length wild type (cells 1 and 6) or deleted (cells 2-5) mtDNA. Single species of D-mtDNA by single-molecule PCR in cells 2-5 indicated a hallmark of clonal expansion of D-mtDNA. As expected, some of the cells did not contain D-mtDNA, which is consistent with the finding that not all respiratory enzyme-deficient cells lacked complex IV subunit-I. The single-molecule PCR performed more than three times from DNA extracted from single cells is shown in Supplementary Fig. 5 (iNOS, Fig. 5 ; Table 2 ). NOX1 was expressed in stromal cells and CP epithelium in MS compared with discrete NOX1 positive epithelial cells in PD, AD and controls ( Fig. 5ai-dii) . In contrast, p22phox, MPO and iNOS were rarely detected in the epithelium (Fig. 5e-p) ; percentage of respiratory enzyme-deficient cells without p22phox, MPO and iNOS was 3.09 ± 0.70, 3.49 ± 1.21 and 3.23 ± 0.94 %, respectively, similar to the density of respiratory enzyme-deficient cells detected by complex IV/complex II histochemistry (Fig. 1) . However, there were significantly more NOX1, MPO and iNOS positive cells within CP stroma in MS than PD, AD and controls ( Table 2 ). The supposed increase in RONS in MS was supported by a significant increase in CD68 positive cells and HLA immunoreactivity ( Supplementary Fig. 4 and Table 2 ).
Discussion
Here, we establish high levels of clonally expanded D-mtDNA within significantly more respiratory enzymedeficient CP epithelial cells in MS than AD, PD and controls. Although we detected multiple D-mtDNA when CP epithelial cells were combined, single cell analysis using longrange PCR and single-molecule PCR (a relatively error resistant method [28] ) showed hallmarks of clonal expansion of single D-mtDNA in MS. Given the numerous hotspots in the mitochondrial genome for double strand breaks, it is unlikely that de novo mutagenesis would increase the level of the same clone of D-mtDNA in a single cell [24] . The loss of complex IV subunit-I in a greater proportion of respiratory enzyme-deficient cells in MS is consistent with the pathogenicity of high level of D-mtDNA, as previously noted in non-epithelial cells [2, 22, 25] .
The CP epithelium is a metabolically highly active structure where proteins and a number of metabolites and neurotransmitters are actively transported across the blood-CSF barrier [40, 46] . The respiratory deficiency in the CP epithelium has been suggested as the cause of elevated CSF protein levels in cases with Kearns-Sayre syndrome (KSS), which is due to a large-scale single sporadic D-mtDNA [38] . Furthermore, the D-mtDNA led respiratory enzyme deficiency was implicated in the cerebral folate deficiency and the distinct profile of CSF metabolites in KSS [39, 41, 42] . Similarly, the D-mtDNA led respiratory enzyme deficiency may contribute to the raised CSF protein levels and possibly a decrease in CSF folate levels in MS [29] . Alternatively, the high level of clonally expanded D-mtDNA and the resulting respiratory enzyme failure may be an epiphenomenon in the CP epithelium. Nevertheless, future studies are necessary to reveal the role of respiratory enzyme-deficient epithelial cells in the function of the CP and the pathogenesis of AD, PD and MS, including the entry of T cells across the blood-CSF barrier.
Interestingly, the ultrastructural changes of mitochondria within CP epithelial cells have been noted in experimental autoimmune encephalomyelitis (EAE), suggesting that the injury to mitochondria within the CP epithelium in MS may begin during the early stage of MS [15] . The formation of D-mtDNA at a young age and the prolonged disease duration in MS cases compared with other neurodegenerative disorders is likely to provide a greater opportunity for D-mtDNA clonal expansion in MS. Based on the proposed kinetics of clonal expansion of D-mtDNA in neurodegenerative disorders, the biochemical defects may not establish until several years have lapsed from the initial injury to mtDNA [24, 25, 28] . The rate of cortical atrophy in MS peaks during the onset of progressive disease, which may be a decade or so from the onset of relapsing remitting disease and may parallel clonal expansion. In this respect, clonal expansion of D-mtDNA in MS is a potential molecular link between inflammation and a delayed cellular energy failure in CP, as well as within neurons. In addition to the disease duration, the diffuse and chronic inflammation may give rise to more D-mtDNA formation in different cells and increase the prevalence of clonally expanded D-mtDNA in single cells [13, 17] . Furthermore, factors in the chronically inflamed tissue such as NO may increase the rate of clonal expansion in MS through increased mtDNA replication [19, 24, 30] . There is the . a-d In MS, nicotinamide adenine dinucleotide phosphate (NADH) oxidase (NOX1) was diffusely expressed within the epithelium (ai) as well as in stromal cells (aii). In contrast, NOX1 was restricted to discrete epithelial cells in PD, AD and controls (bi-ii, ci-ii, di-ii). Several respiratory enzyme-deficient cells with faint NOX1 expression were apparent in MS (aiii, arrowhead), whereas the majority of respiratory enzyme-deficient cells in PD (biii, arrowhead), AD (ciii, arrowhead) and controls (diii, arrowhead) were not positive for NOX1 (see Table 2 for quantitative data). Scale bar 100 lm (ai-dii) and 30 lm (aiii-diii). e-p NADPH oxidase subunit P22phox (e-h), myeloperoxidase (MPO, i-l) and inducible nitric oxide synthase (iNOS, m-o) were not detected within epithelium in any of the four groups. MPO positive cells were present within stroma and occasionally in blood vessels (i-l). Interestingly, respiratory enzyme-deficient cells in any of the four groups were not positive for p22phox (e-h, arrowheads), MPO (iii-lii, arrowheads) or iNOS (m-p), also reflected by quantitative data, with percentage of respiratory enzyme-deficient cells negative for RONS sources being similar to respiratory enzymedeficient cell density by complex IV/complex II histochemistry. Scale bar 40 lm (m-p) suggestion that factors other than disease duration influence clonal expansion in MS; the second and third highest proportion of respiratory enzyme-deficient cells harbouring clonally expanded D-mtDNA were found in the 42-and 44-year-old MS cases (with 12 and 10 years of clinical disease). However, the duration of the subclinical phase of MS and indeed AD and PD is not known and may influence the biochemical outcome of induced D-mtDNA in these cases. Understanding the extrinsic factors that influence both the formation and subsequent clonal expansion of D-mtDNA in inflammatory environments may identify potential therapeutic targets to prevent the D-mtDNA led respiratory enzyme deficiency in a number of neurodegenerative disorders. Although mitochondrial respiratory chain defects have been described in animal models of MS, including within the CP, mtDNA has not yet been studied [15, 34, 44] . Given the prolonged disease duration and lag between clinical onset of MS and onset of progression, the window of opportunity to prevent clonal expansion of D-mtDNA may be greater in secondary progressive MS patients than other neurodegenerative disorders.
The clonally expanded D-mtDNA did not explain the biochemical defect in the majority of respiratory enzymedeficient cells. The post-transcriptional and post-translational modifications of respiratory chain subunits as well as inhibition of mitochondrial respiratory chain complexes may, at least in part, explain the biochemical defect in the remaining cells in MS, as well as in AD, PD and controls. Indeed, oxidative damage to proteins within the CP has been reported in AD [33] . In PD, the lack of D-mtDNA at high levels within CP is consistent with the proposal that the D-mtDNA led respiratory enzyme deficiency is restricted to the dopaminergic system [1] .
In summary, we establish clonal expansion of D-mtDNA to high levels in MS as a relatively prominent feature compared with AD, PD and controls, using an extraparenchymal structure (CP) that is detached from demyelination and yet involved in the inflammatory process in MS. These findings together with the previous report of D-mtDNA within neurons in MS [6] highlight the potential importance of understanding the dynamics of clonal expansion of D-mtDNA and the resulting cellular energy failure, particularly in chronic inflammatory demyelinating environments such as in MS.
